Life,
Journal Year:
2024,
Volume and Issue:
14(9), P. 1194 - 1194
Published: Sept. 21, 2024
Our
aim
was
to
investigate
the
diagnostic
challenges
and
management
of
relapsing
polychondritis
(RP)
with
airway
involvement,
highlighting
need
for
accurate
diagnosis
effective
intervention
prevent
severe
complications.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 13, 2025
AbstractObjectives
The
triggers
of
relapsing
polychondritis
(RPC)
are
not
fully
characterized.
This
study
was
performed
to
explore
the
association
between
physical
trauma
and
RPC.
Methods
history
208
patients
with
RPC
from
a
Chinese
cohort
reviewed
compared
that
1134
rheumatoid
arthritis
(RA)
369
psoriatic
(PsA).
characteristics
survival
were
analyzed.
Results
Eighty
(38.5%)
ever
had
trauma.
number
is
considerably
higher
than
RA
(21.6%,
p
<
0.0001)
PsA
(20.6%,
0.0001).
A
total
48
(23.1%)
52
osteochondral
injuries,
whereas
only
58
(5.1%,
21
(5.7%,
injuries.
We
found
more
experienced
any
type
trauma,
as
well
in
preceding
one
year
,
also
half
year,
before
disease
onset
PsA.
Traumatic
events
(osteochondral
nonosteochondral)
increased
onset,
especially
six
months.
Patients
occurred
at
time
rate
airway
involvement
lower
rates
those
without
Conclusion
Our
findings
suggest
may
be
RPC,
seem
have
severe
without.
Immunity Inflammation and Disease,
Journal Year:
2025,
Volume and Issue:
13(2)
Published: Feb. 1, 2025
ABSTRACT
Background
Relapsing
polychondritis
(RP)
is
a
rare
autoimmune
disorder
characterized
by
episodic
inflammation
of
cartilaginous
tissues.
Its
diverse
clinical
manifestations
frequently
pose
diagnostic
challenges
and
lead
to
misdiagnosis.
Methods
We
present
59‐year‐old
female
initially
diagnosed
with
refractory
hip
osteoarthritis
based
on
persistent
left
pain
unresponsive
conventional
anti‐inflammatory
therapy.
Subsequent
development
stridor
dyspnea
prompted
comprehensive
evaluation,
including
laryngotracheal
imaging,
serology,
multidisciplinary
consultation.
Diagnostic
criteria
for
RP
were
applied
in
accordance
revised
Michet
criteria.
Results
Tracheal
stenosis
secondary
tracheal
chondritis
iritis
identified,
confirming
the
diagnosis
RP.
Following
initiation
corticosteroid
therapy,
patient
exhibited
marked
improvement.
Conclusion
This
case
underscores
importance
enhanced
awareness
regarding
atypical
presentations
RP,
particularly
when
accompanied
evolving
systemic
symptoms.
A
approach
advocated
facilitate
early
detection
improve
outcomes.
RMD Open,
Journal Year:
2025,
Volume and Issue:
11(2), P. e005397 - e005397
Published: April 1, 2025
Introduction/objectives
Relapsing
polychondritis
(RP)
is
a
rare
autoimmune
disorder
primarily
affecting
cartilaginous
structures.
We
aimed
to
characterise
the
clinical
features
and
CT
findings
of
laryngeal
involvement
in
RP,
hypothesising
that
specific
patterns
correlate
with
manifestations.
Methods
retrospectively
analysed
173
patients
confirmed
RP.
Demographic
data
were
collected,
laryngeal,
tracheal,
bronchial
reviewed.
Statistical
analyses
identified
factors
associated
airway
stenosis.
Results
Notably,
66%
asymptomatic
displayed
evidence
damage,
41.1%
(44/107),
tracheal
80.9%
(140/173),
36.4%
(63/107).
Cricoid
erosion
broadening
mucosal
hyperplasia
predominant
findings.
Significant
associations
included
younger
age
at
disease
onset
(p<0.05),
longer
duration
(p<0.01)
multiorgan
manifestations
(p<0.01).
Conclusions
Laryngeal
common
RP
manifestations,
second
only
involvement.
cricoid
are
characteristic.
Vigilant
monitoring
recommended
for
risk
facilitate
early
detection
management.
Future
research
should
focus
on
developing
targeted
interventions
this
high-risk
subgroup
patients.
Immunotherapy,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 5
Published: Dec. 20, 2024
Relapsing
polychondritis
is
rare
and
affects
non-synovial
fibrocartilage.
Currently,
there
a
paucity
of
treatment
algorithms,
especially
for
those
with
refractory
disease.
A
middle-aged
man
presented
affecting
the
nose,
ears,
joints,
larynx.
Two
months
prior,
diagnosis
non-arteritic
ischemic
optic
neuropathy
was
made.
Oral
prednisolone
initiated,
over
following
three
years,
he
had
several
flares
which
other
treatments
were
given:
moderate
dose
methotrexate
(elevated
liver
enzymes),
azathioprine
(gastrointestinal
intolerance),
mycophenolate
(ineffective),
tocilizumab
(widespread
eruption),
tofacitinib
(acute
diverticulitis).
Further
investigations
unremarkable
malignancy
vasculitis.
UBA1
mutation
screening
negative.
Given
limited
therapeutic
options,
at
lower
re-added,
but
developed
acute
flare
laryngeal
symptoms.
Anakinra
prompting
successful
wean
weeks
disease
remission.
literature
review
identified
11
publications
comprising
25
patients.
Of
21
patients
anakinra
response
documented,
six
(28.6%)
symptomatic
improvement.
In
one
these
patients,
co-administration
methotrexate.
summary,
may
remain
as
an
option,
only
subsets
in
whom
many
more
efficacious
have
been
tried
to
provide
sustained
control.